New search | Conferencedetail
mail
Print view
 
 

AI IN DRUG DISCOVERY USA

Evvnt Promotion / evvnt
-
21.10.2024 - 22.10.2024  Courtyard Boston Downtown, 275 Tremont Street, 02116 Boston, Massachusetts, USA
Time: 8:00 AM - 4:30 PM
 
Conference themes
Artificial Intelligence (AI) is leading technological advancements in the pharmaceutical sector, poised to transform pre-clinical drug discovery by reducing costs by up to 40% and creating a market valued at up to $50 billion in the next decade. This transformative period is upon us, and the AI in Drug Discovery conference offers a unique opportunity to hear directly from experts and gain strategies to enhance your operations.
Target Audience
The conference is ideal for companies aiming to expedite the delivery of therapeutics to patients, thereby extending healthy longevity. Attendees will learn how to build an AI ecosystem by combining internal and external resources
Professional congress organizer (PCO)
SAE Media Group
Notes
URL:
Brochure: https://go.evvnt.com/2449688-2?pid=4832

Speakers: DR BINO JOHN - Director, Computational Biology, Cancer Immunology and Immune Modulation, Boehringer Ingelheim, DR DMITRIY PODOLSKIY - Associate Director, Astellas Pharma, and more
 

Enquiries and Registration:

https://go.evvnt.com/2449688-0?pid=4832
Mr. Elliot Karmel
 
Categories
General Medicine
Languages
English
Congress fees
AI in Drug Discovery (EARLY BIRD DISCOUNT UNTIL 09/06/24): USD 2399.00
Participants expected
150 - 150
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

AMREF - African Medical and Research FoundationnewTreeAnästhesie in Entwicklungsländern e. V.Swiss Tropical and Public Health InstituteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÄrztekammer für WienOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Österreichisches Rotes Kreuz